Massive blood disorder registry aims to transform care

NCT ID NCT06820515

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is a large registry that collects health information from up to 200,000 people with blood disorders such as hemophilia, thrombosis, and sickle cell disease. Participants are seen at Hemophilia Treatment Centers across the U.S. The goal is to gather real-world data to help doctors, researchers, and policymakers improve treatment and public health reporting. No experimental treatments are given; it is purely observational.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this registry could provide insights that lead to better treatments and care guidelines for people with blood disorders.

What could go wrong

This is an observational registry, not a treatment trial. It collects data but does not test any intervention, so direct benefits to participants are unlikely.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEMOPHILIA A are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Glanzmann thrombasthenia Glanzmann thrombasthenia 1 hemarthrosis hematologic disorder hemophilia hemophilia A hemophilia B hemorrhagic disease hereditary von Willebrand disease sickle cell disease thrombotic disease vascular hemostatic disease von Willebrand disease (hereditary or acquired)

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • American Thrombosis and Hemostasis Network

    RECRUITING

    Hickory, North Carolina, 28601, United States

    Contact Email: •••••@•••••